Filing Details

Accession Number:
0001415889-21-003569
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-09 13:36:49
Reporting Period:
2021-07-07
Accepted Time:
2021-07-09 13:36:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818844 Virios Therapeutics Inc. VIRI Pharmaceutical Preparations (2834) 854314201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826115 William Pridgen 44 Milton Avenue
Alpharetta GA 30009
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-07 942 $6.32 710,734 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,500 Indirect 401 (k) Account
Footnotes
  1. This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
  2. Does not include 18,201 shares that were previously reported on the reporting person's Form 3 and prior Forms 4. Such shares were included in the person's holdings in error.
  3. The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.